ECOG-ACRIN EA5181

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Lung, Lung - Non-Small Cell

Status:

Closed

Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC

Eligible for screening study DCP 001

EA5181 is closed to accrual, effective November 20, 2013

NCT#04092283